Use of siramesine in the treatment of cancer

Details for Australian Patent Application No. 2004298722 (hide)

International Classifications

Event Publications

22 June 2006 PCT application entered the National Phase

PCT publication WO2005/058324 Priority application(s): WO2005/058324

13 July 2006 Amendment Made

The nature of the amendment is: Delete priority details 60/531,670 19 Dec 2003 US 2004308653 Gruenenthal GmbH The nature of the amendment is: Amend the invention title to read Process for the production of an abuse-proofed dosage form 2004312739 3M Innovative Properties Company The nature of the amendment is: Amend the invention title to read Use of fluorinated nonionic surfactants for reducing nonspecific binding of molecules to a surface 2005

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.